C13H14N2O2S, triclinic, P1̅ (no. 2), a = 4.8885(2) Å, b = 10.3414(5) Å, c = 12.6056(6) Å, α = 95.162(2)°, β = 97.487(1)°, γ = 101.494°, V = 614.73(5) Å3, Z = 2, Rgt(F) = 0.0507, wRref(F2) = 0.1149, T = 100 K
C11H14N2O5S, monoclinic, P12(1)/cl (no. 14), a = 7.4329(9) angstrom, b = 23.631(3) angstrom, c = 7.9...
C34H54N10O6S6, monoclinic, P21 (no. 4), a = 11.8434(5) Å, b = 11.2298(6) Å, c = 17.0706(8) Å, β = 94...
C16H14N2O4S, monoclinic, P121/n1 (No. 14), a = 6.291(6) Å, b = 23.73(1) Å, c = 10.175(7) Å, β = 92.6...
In the title compound, C12H14N2O2S2, the dihydropyrimidine ring adopts a sofa conformation, with the...
C21H18N2O3S, triclinic, P1̄ (No. 2), a = 8.766(6) Å, b = 13.67(1) Å, c = 8.274(5) Å, α = 90.88(8)°, ...
C14H12N4O3S, monoclinic, P21/n (no. 14), a = 12.2777(3) Å, b = 9.4312(2) Å, c = 12.9412(2) Å, β = 10...
C24H30N4O6S2, triclinic, P1̄ with a = 9.2557(4) Å, b = 10.2606(5) Å, c = 14.0972(7) Å, α = 71.949(2)...
C16H16FN3OS, triclinic, P1̅ (no. 2), a = 5.6885(3) Å, b = 9.4378(4) Å, c = 15.0736(7) Å, α = 84.037(...
C14H14N2O2S, triclinic, P1̄, a = 8.6471(4) Å, b = 9.5576(5) Å, c = 9.7098(5) Å, α = 91.054(2)°, β = ...
C15H18N2O4S2, monoclinic, P121/c1 (No. 14), a = 8.754(3) Å, b = 12.499(2) Å, c = 15.599(3) Å, β = 95...
The title compound, C6H6N6S, crystallized with two independent mol-ecules (A and B) in the asymmetri...
C30H25N3O4S2, monoclinic, P121/c1 (No. 14), a = 7.031(2) Å, b = 33.12(1) Å, c = 13.149(4) Å, β = 119...
In the title pyrimidine-2,4-dione derivative, C14H16N2O2S, the dihedral angle between the six-member...
C15H18N2O4S2, monoclinic, P12/c1 (No. 14), a = 8.754(3) \uc5, b = 12.499(2) \uc5, c = 15.599(3) \uc5...
C19H18N4O6S, monoclinic, P21/n (no. 14), a = 8.343(4) Å, b = 7.367(3) Å, c = 31.532(14) Å, β = 97.39...
C11H14N2O5S, monoclinic, P12(1)/cl (no. 14), a = 7.4329(9) angstrom, b = 23.631(3) angstrom, c = 7.9...
C34H54N10O6S6, monoclinic, P21 (no. 4), a = 11.8434(5) Å, b = 11.2298(6) Å, c = 17.0706(8) Å, β = 94...
C16H14N2O4S, monoclinic, P121/n1 (No. 14), a = 6.291(6) Å, b = 23.73(1) Å, c = 10.175(7) Å, β = 92.6...
In the title compound, C12H14N2O2S2, the dihydropyrimidine ring adopts a sofa conformation, with the...
C21H18N2O3S, triclinic, P1̄ (No. 2), a = 8.766(6) Å, b = 13.67(1) Å, c = 8.274(5) Å, α = 90.88(8)°, ...
C14H12N4O3S, monoclinic, P21/n (no. 14), a = 12.2777(3) Å, b = 9.4312(2) Å, c = 12.9412(2) Å, β = 10...
C24H30N4O6S2, triclinic, P1̄ with a = 9.2557(4) Å, b = 10.2606(5) Å, c = 14.0972(7) Å, α = 71.949(2)...
C16H16FN3OS, triclinic, P1̅ (no. 2), a = 5.6885(3) Å, b = 9.4378(4) Å, c = 15.0736(7) Å, α = 84.037(...
C14H14N2O2S, triclinic, P1̄, a = 8.6471(4) Å, b = 9.5576(5) Å, c = 9.7098(5) Å, α = 91.054(2)°, β = ...
C15H18N2O4S2, monoclinic, P121/c1 (No. 14), a = 8.754(3) Å, b = 12.499(2) Å, c = 15.599(3) Å, β = 95...
The title compound, C6H6N6S, crystallized with two independent mol-ecules (A and B) in the asymmetri...
C30H25N3O4S2, monoclinic, P121/c1 (No. 14), a = 7.031(2) Å, b = 33.12(1) Å, c = 13.149(4) Å, β = 119...
In the title pyrimidine-2,4-dione derivative, C14H16N2O2S, the dihedral angle between the six-member...
C15H18N2O4S2, monoclinic, P12/c1 (No. 14), a = 8.754(3) \uc5, b = 12.499(2) \uc5, c = 15.599(3) \uc5...
C19H18N4O6S, monoclinic, P21/n (no. 14), a = 8.343(4) Å, b = 7.367(3) Å, c = 31.532(14) Å, β = 97.39...
C11H14N2O5S, monoclinic, P12(1)/cl (no. 14), a = 7.4329(9) angstrom, b = 23.631(3) angstrom, c = 7.9...
C34H54N10O6S6, monoclinic, P21 (no. 4), a = 11.8434(5) Å, b = 11.2298(6) Å, c = 17.0706(8) Å, β = 94...
C16H14N2O4S, monoclinic, P121/n1 (No. 14), a = 6.291(6) Å, b = 23.73(1) Å, c = 10.175(7) Å, β = 92.6...